Efficacy and Safety of AEYE Diagnostic Screening (AEYE-DS) Software Device for Detection of Diabetic Retinopathy From Digital Funduscopic Images

NACompletedINTERVENTIONAL
Enrollment

601

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

October 2, 2024

Study Completion Date

February 20, 2025

Conditions
Diabetic Retinopathy, DRDiabetic Mellitus
Interventions
DEVICE

AEYE-DS Software

An Artificial Intelligence (AI) software device to be used as a diagnostic tool to assist healthcare providers in screening for diabetic retinopathy (DR) using digital funduscopic images. The device automatically detects more than mild diabetic retinopathy (mtmDR) in adults diagnosed with diabetes who have not been previously diagnosed with DR.

Trial Locations (1)

77074

Clinical Trial Network, Houston

All Listed Sponsors
collaborator

A. Stein Regulatory Affairs Consulting Ltd.

UNKNOWN

lead

AEYE Health Inc

INDUSTRY